springtree at work, page-61

Personally l'm becoming tired of hearing about Springtree, yes they are selling and influencing the price, and yes they are also providing critical funding going forward. Having said that, Prima Biomed, not Springtree, are the masters of their own destiny. When we are trading at .25 cents, then Springtree's activities won't change, they'll simply be trading at a different level. Laurence Freedman, who we know is Director of Link Traders (Aust) Pty Ltd, owns just under 45 million shares in PRR. He purchased 8.1 million shares as recently as Feb 23rd this year - now if he starts selling, then l'll take notice, but Springtree's selling doesn't faze me at all.